Market Place
Sourcing Support
Scorpius Holdings Announces Corporate Update and Expansion
04 May 2025 //
GLOBENEWSWIRE
Scorpius Holdings Updates 2024 Business with Cost Reductions
30 Apr 2025 //
GLOBENEWSWIRE
Scorpius Holdings to Appeal NYSE American Delisting Notice
21 Apr 2025 //
GLOBENEWSWIRE
Scorpius Holding Engages Alliance Global For Strategic Alternatives
26 Feb 2025 //
GLOBENEWSWIRE
Scorpius, KaloCyte Partner To Enhance ErythroMer Manufacturing
22 Jan 2025 //
CONTRACTPHARMA
Scorpius Holdings Cancels Planned Reverse Stock Split
17 Jan 2025 //
GLOBENEWSWIRE
Scorpius Holdings Announces Reverse Stock Split
16 Jan 2025 //
GLOBENEWSWIRE
Scorpius Holdings Introduces Scorpius Ventures
19 Nov 2024 //
CONTRACTPHARMA
Scorpius Holdings Q3 Results Highlight Partnerships, Progress
14 Nov 2024 //
GLOBENEWSWIRE
Scorpius Holdings Partners with Celltheon for Cell Line Development
04 Nov 2024 //
GLOBENEWSWIRE
Scorpius Holdings Implements $2M Annual Cost Savings
31 Oct 2024 //
GLOBENEWSWIRE
Scorpius Holdings Announces Partnership with U.S. Biotech Company
22 Oct 2024 //
GLOBENEWSWIRE
Scorpius Holdings Joins CBRN Defense Consortium
02 Oct 2024 //
GLOBENEWSWIRE
Scorpius Holdings Signs Contract With Clinical-Stage Biotech Firm
30 Sep 2024 //
GLOBENEWSWIRE
Scorpius Holdings Commends House Passage Of BIOSECURE Act
12 Sep 2024 //
GLOBENEWSWIRE
Scorpius Selected For RRPV To Support BARDA
09 Sep 2024 //
GLOBENEWSWIRE
Scilex To Present At H.C. Wainwright Global Conference
09 Sep 2024 //
GLOBENEWSWIRE
Scorpius Holdings CEO Updates on Expanding Sales Pipeline and Cash Flow Progress
26 Aug 2024 //
GLOBENEWSWIRE
Scorpius Holdings CEO Provides Update On Sales Pipeline And Manufacturing
26 Aug 2024 //
GLOBENEWSWIRE
Scorpius Holdings CEO Provides Corporate Update
26 Aug 2024 //
CONTRACT PHARMA
Scorpius Holdings Reports 16% YOY Revenue Increase In Q2 2024
20 Aug 2024 //
GLOBENEWSWIRE
Scorpius Holdings, Inc. Announces Closing of Public Offering
19 Aug 2024 //
GLOBENEWSWIRE
Scorpius Holdings, Inc. Announces Pricing of Public Offering
16 Aug 2024 //
GLOBENEWSWIRE
Scilex Enters Distribution Agreement For ZTlido® In Multiple Countries
09 Aug 2024 //
GLOBENEWSWIRE
Scorpius Holdings Updates On Public Offering
09 Aug 2024 //
GLOBENEWSWIRE
Scorpius Holdings To Resume NYSE American Trading August 2
30 Jul 2024 //
GLOBENEWSWIRE
Scorpius To Launch First Mammalian cGMP Campaign In Q3 2024
24 Jul 2024 //
GLOBENEWSWIRE
Scorpius Holdings Executes First CGMP Microbial Batches At San Antonio
18 Jul 2024 //
GLOBENEWSWIRE
Scorpius Holdings Announces Reverse Stock Split
17 Jul 2024 //
GLOBENEWSWIRE
Scorpius Holdings Receives NYSE Notice Of Delisting And Plans To Appeal
17 Jun 2024 //
GLOBENEWSWIRE
Scorpius, Beyond Imagination Partner For AI Humanoid Bio-Manufacturing
03 Jun 2024 //
GLOBENEWSWIRE
Scorpius Holdings Reports 359% YoY Revenue Growth For Q1 2024
29 May 2024 //
PRESS RELEASE
Scorpius Q1 2024 Revenue Up 359% Year-Over-Year
29 May 2024 //
GLOBENEWSWIRE
Scorpius Announces Major San Antonio Expansion
20 May 2024 //
GLOBENEWSWIRE
Scorpius Holdings Expands Operations in San Antonio
20 May 2024 //
CONTRACT PHARMA
Scorpius Commends Congress On Biomanufacturing Legislative Action
16 May 2024 //
PRESS RELEASE
Scorpius Holdings, Inc. Announces Closing of Public Offering
16 May 2024 //
GLOBENEWSWIRE
Scorpius Achieves Microbial Manufacturing Facility Validation Milestone
15 May 2024 //
GLOBENEWSWIRE
Scorpius Holdings, Inc. Announces Pricing of Public Offering
14 May 2024 //
GLOBENEWSWIRE
Scorpius Holdings Appoints New VP of Business Development Shari Udoff-McDonald
07 May 2024 //
GLOBENEWSWIRE
Scorpius 2023 Update: Q4 Revenue Up 570% Sequentially
29 Apr 2024 //
GLOBENEWSWIRE
Scorpius Holdings Announces Receipt of Filing Delinquency Notification
22 Apr 2024 //
GLOBENEWSWIRE
Scorpius Awarded Contract over $1 M with NIH-Funded Researcher
19 Mar 2024 //
GLOBENEWSWIRE
Scorpius Holdings Accepted as a Member of the US Government’s BioMaP-Consortium
14 Mar 2024 //
PRESS RELEASE
Scorpius Holdings Estimates 375%+ Revenue Increase Q4 2023 Vs Q3 2023
07 Mar 2024 //
PRESS RELEASE
NightHawk Biosciences Rebrands As Scorpius Holdings, Trading As "SCPX"
06 Feb 2024 //
PRESS RELEASE
Joe Payne Promoted To President And COO At Scorpius BioManufacturing
01 Feb 2024 //
PRESS RELEASE
NightHawk Receives $3.25M From IP Sale And Low-Interest Note Issuance
30 Jan 2024 //
PRESS RELEASE
Scorpius BioManufacturing Wins Multimillion-Dollar Phase 2 Clinical Contract
25 Jan 2024 //
PRESS RELEASE
Scorpius BioManufacturing Begins Work On New Client`s Preclinical Program
16 Jan 2024 //
PRESS RELEASE
NightHawk To Rebrand As Scorpius Holdings, Focusing On CDMO Services
08 Jan 2024 //
PRESS RELEASE
NightHawk Starts Multi-Million-Dollar Project For Leading National University
03 Jan 2024 //
PRESS RELEASE
